Barriers and facilitators of antiseizure medication adherence: a qualitative study among persons with epilepsy in Pakistan
Bushra Batool Zahra, Muhammad Amir Hamza, Rehana Sarwat, Sharon Floric, Maria Tanveer, Anam Fatima, Muhammad Tariq Khan, Mudassar Iqbal Arain, Ali Ahmed

TL;DR
This study explores why people with epilepsy in Pakistan struggle to stick to their medication and what might help them do better.
Contribution
The study identifies specific barriers and facilitators to ASM adherence in Pakistan through qualitative insights from patients and caregivers.
Findings
Stigma, psychological issues, and financial instability hinder medication adherence among persons with epilepsy.
Free treatment facilities and availability of healthcare providers support better adherence.
Medication side effects and unavailability of ASMs are major obstacles to adherence.
Abstract
Medication adherence is crucial to achieving optimal health outcomes in persons with epilepsy. Approximately 52.1% of persons with epilepsy are sub-optimally adherent to antiseizure medications (ASMs) in Pakistan, leading to increased risk of drug resistance and mortality. Achieving adherence in Pakistan is challenging because of socioeconomic, psychological, and cultural factors. In this qualitative study, we identified the factors that hinder or support adherence to medication regimens and explored the lived experiences of persons with epilepsy regarding adherence to ASMs. Twenty-eight qualitative interviews were conducted with persons with epilepsy who visited the largest hospital in Islamabad, Pakistan Institute of Medical Sciences (PIMS), from March to June 2024. Clinically diagnosed persons with epilepsy with their caregivers (CGs), were invited to participate in this study. This…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEpilepsy research and treatment · Pharmacological Effects and Toxicity Studies · Bipolar Disorder and Treatment
